CAS NO: | 2055597-39-0 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | ERK-IN-3 benzenesulfonate is a potent and orally active inhibitor ofERK. ERK-IN-3 benzenesulfonate inhibitsERK1/2with low single-digit nMIC50values. ERK-IN-3 benzenesulfonate can be used for the research of cancers driven byRASmutations[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | ERK-IN-3 inhibits the phosphorylation of ERK1/2 substrates such as RSK1, FRA1, and Elk1 in various cell lines[1]. | ||||||||||||||||
体内研究 (In Vivo) | ERK-IN-3 (daily p.o.) inhibits tumor growth in multiple BRAF and KRAS mutant xenograft models in mice and was well tolerated at efficacious doses[1]. | ||||||||||||||||
分子量 | 632.11 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C28H31ClFN7O5S | ||||||||||||||||
CAS 号 | 2055597-39-0 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 320 mg/mL(506.24 mM;Need ultrasonic) H2O : 100 mg/mL(158.20 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|